The Ontarian Courts are finally cracking down on FSD Pharma's Executives, especially Dr.
Raza Bokhari and other board members, Stephen Buyer,
Robert Ciaruffoli,
James Datin,
Gerald Goldberg and Larry Kaiser, for purposely diluting its shares.
When FSD Pharma has their Shareholder Meeting on May 14, 2021, Dr. Bokhari will also be banned from presiding as a Chairperson, especially using recently acquired shares.
In other words, an independent person will preside over it so that the meeting will go against Dr. Bokhari's favour.
Perhaps this newest development will be the begging of great things for FSD Pharma general shareholders like myself.
Finally, share manipulation and value dilusion is coming to an end.
Victory for the little HUGE investors.
Source: Yahoo Finance "Court Orders FSD Pharma to Move Shareholder Meeting Date to May 14, 2021, Imposes Requirement of an Independent Meeting Chair and Prevents Dr. Raza Bokhari and Other Directors from Voting Recently Issued Shares" - https://finance.yahoo.com/finance/news/court-orders-fsd-pharma-move-120000326.html